10.1016/j.biopsych.2004.11.035 Biol
Implications for employers : Employers should expect coverage of GLP-1 drugs for obesity to improve population health and employee productivity, but the return on investment from coverage is not likely to lead to lower medical costs now or in the future
The predicted binding pose revealed that the compound establishes stabilizing interactions with a set of hydrophobic and aromatic residues lining the transmembrane binding cavity (Figure 4), including A200, L201, M204, L217, Y220, V229, and W297
Aligned with our Leadership Principles, Ascendis Pharma places strong emphasis on developing leadership capabilities at all levels of the organization, recognizing this as essential to fostering a motivated and engaged workforce
Because eosinophils and MQs both express LFA-1 molecules, this suggests a possible goal for treatments targeting airway inflammation